These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6286550)

  • 1. Influence of WR 2721 on the efficacy of radiotherapy and chemotherapy of murine tumors.
    Clement JJ; Johnson RK
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):539-42. PubMed ID: 6286550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental radiotherapy with WR-2721 and misonidazole.
    Rojas A; Stewart FA; Denekamp J
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):527-30. PubMed ID: 6286547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tumor type, size, and endpoint on tumor radioprotection by WR-2721.
    Milas L; Hunter N; Ito H; Peters LJ
    Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):41-8. PubMed ID: 6321411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of WR-2721 in radiotherapy and/or chemotherapy.
    Yuhas JM; Spellman JM; Culo F
    Cancer Clin Trials; 1980; 3(3):211-6. PubMed ID: 6254681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification by WR 2721 of the response to chemotherapy of tumours and normal tissues in the mouse.
    Twentyman PR
    Br J Cancer; 1983 Jan; 47(1):57-63. PubMed ID: 6295428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the radioprotector WR 2721 on the response of metastatic Lewis lung carcinoma colonies to alkylating agents.
    Wist EA
    Acta Radiol Oncol; 1985; 24(3):259-62. PubMed ID: 2994377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
    Green D; Bensely D; Schein P
    Cancer Res; 1994 Feb; 54(3):738-41. PubMed ID: 8306335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postirradiation glucan administration enhances the radioprotective effects of WR-2721.
    Patchen ML; MacVittie TJ; Jackson WE
    Radiat Res; 1989 Jan; 117(1):59-69. PubMed ID: 2536480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution.
    Rasey JS; Nelson NJ; Mahler P; Anderson K; Krohn KA; Menard T
    Radiat Res; 1984 Mar; 97(3):598-607. PubMed ID: 6328565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of bone marrow by WR-2721 after fractionated irradiation.
    Coia LR; Brown DQ
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):908-9. PubMed ID: 2550401
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxygen-dependent protection of radiation lung damage in mice by WR 2721.
    Down JD; Laurent GJ; McAnulty RJ; Steel GG
    Int J Radiat Biol Relat Stud Phys Chem Med; 1984 Nov; 46(5):597-607. PubMed ID: 6097559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
    Rojas A; Stewart FA; Denekamp J
    Br J Cancer; 1983 Jan; 47(1):65-72. PubMed ID: 6295429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by Wr-2721.
    Wasserman TH; Phillips TL; Ross G; Kane LJ
    Cancer Clin Trials; 1981; 4(1):3-6. PubMed ID: 6260393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
    Twentyman PR
    Br J Cancer; 1981 Jun; 43(6):745-55. PubMed ID: 6264941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of amifostine: from cytoprotectant to therapeutic agent.
    Santini V; Giles FJ
    Haematologica; 1999 Nov; 84(11):1035-42. PubMed ID: 10553165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the radioprotective drugs MEA, DMSO, and WR-2721 on tumor control and skin tolerance in the rat.
    Moulder JE; Lo PS; Fischer JJ
    Cancer Treat Rep; 1977 Aug; 61(5):825-33. PubMed ID: 196752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L; Ito H; Hunter N
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of mouse lung by WR-2721 after fractionated doses of irradiation.
    Travis EL; De Luca AM
    Int J Radiat Oncol Biol Phys; 1985 Mar; 11(3):521-6. PubMed ID: 2982773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and radiation protective effect of WR-77913 in BALB/c mice.
    Mendiondo OA; Connor AM; Grigsby P
    Acta Radiol Oncol; 1982; 21(5):319-23. PubMed ID: 6297251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.
    Milas L; McBride WH; Hunter N; Ito H
    Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.